|
2003 Conference Publication The impact of the hyper-CVAD chemotherapy regimen on the ability to mobilize peripheral blood stem cells (PBSC) in patients with hematological malignancies.Mollee, PN, Mills, AK, Grimmett, K, Van Kuilenburg, R, Saal, RJ, Gill, D, Cobcroft, R and Marlton, P (2003). The impact of the hyper-CVAD chemotherapy regimen on the ability to mobilize peripheral blood stem cells (PBSC) in patients with hematological malignancies.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego, CA, United States, 6-9 December 2003. Washington, DC, United States: American Society of Hematology. |
|
2003 Journal Article Measurement of immunoglobulin free light chains in serum - ReplyTate, JR, Mollee, P and Gill, D (2003). Measurement of immunoglobulin free light chains in serum - Reply. Clinical Chemistry, 49 (11), 1958-1958. doi: 10.1373/clinchem.2003.026294 |
|
2003 Journal Article Why aren’t we performing more allografts for aggressive non-Hodgkin’s lymphoma?Mollee, P., Lararus, H. M. and Lipton, J. (2003). Why aren’t we performing more allografts for aggressive non-Hodgkin’s lymphoma?. Bone Marrow Transplantation, 31 (11), 953-960. doi: 10.1038/sj.bmt.1704040 |
|
2003 Journal Article Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtypeSong, Kevin W., Mollee, Peter, Keating, Amanda and Crump, Michael (2003). Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. British Journal of Haematology, 120 (6), 978-985. doi: 10.1046/j.1365-2141.2003.04203.x |
|
2002 Conference Publication Effect of gemcitabine, dexamethasone and cisplatin salvage chemotherapy (GDP) on peripheral blood stem cell (PBSC) mobilization in patients with lymphoma.Mollee, P, Nagy, T, Saragosa, R, Turner, R, Keating, A and Crump, M (2002). Effect of gemcitabine, dexamethasone and cisplatin salvage chemotherapy (GDP) on peripheral blood stem cell (PBSC) mobilization in patients with lymphoma.. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, Dec 06-10, 2002. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2002 Conference Publication Long-term outcome following high-dose therapy with etoposide, melphalan, TBI and autologous stem cell transplantation (ASCT) for acute myeloid leukemia (AML).Mollee, P, Gupta, V, Song, K, Tsang, R, Crump, M and Keating, A (2002). Long-term outcome following high-dose therapy with etoposide, melphalan, TBI and autologous stem cell transplantation (ASCT) for acute myeloid leukemia (AML).. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, Dec 06-10, 2002. |
|
2002 Conference Publication Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL).Mollee, P, Song, K, Keating, A, Tsang, R and Crump, M (2002). Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL).. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, Dec 06-10, 2002. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2002 Journal Article Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphomaSong, KW, Mollee, P, Patterson, B, Brien, W and Crump, M (2002). Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma. British Journal of Haematology, 119 (1), 125-127. doi: 10.1046/j.1365-2141.2002.03778.x |
|
2002 Journal Article Progenitor cell mobilisation - Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphomaMollee, P, Pereira, D, Nagy, T, Song, K, Saragosa, R, Keating, A and Crump, M (2002). Progenitor cell mobilisation - Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma. Bone Marrow Transplantation, 30 (5), 273-278. doi: 10.1038/sj.bmt.1703653 |
|
2002 Conference Publication Allogeneic stem cell transplantation for idiopathic myelofibrosis in AustralasiaDurrant, S, Szer, J, Bradstock, K, Nivison-Smith, I and Mollee, P (2002). Allogeneic stem cell transplantation for idiopathic myelofibrosis in Australasia. 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Canberra Australia, May 11-13, 2005. LONDON: NATURE PUBLISHING GROUP. |
|
2001 Conference Publication Prolonged engraftment and transgene expression of genetically modified autologous bone marrow stromal (mesenchymal) cells after infusion post autotransplant: A platform for cell and gene therapy.Keating, A, Filshie, R, Mollee, P and Wang, XH (2001). Prolonged engraftment and transgene expression of genetically modified autologous bone marrow stromal (mesenchymal) cells after infusion post autotransplant: A platform for cell and gene therapy.. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2001 Journal Article Single institution outcomes of treatment of severe aplastic anaemiaMollee, P., Woodward, N., Durrant, S., Lockwood, L., Gillett, E. A., Morton, J. and Rowell, J. (2001). Single institution outcomes of treatment of severe aplastic anaemia. Internal Medicine Journal, 31 (6), 337-342. doi: 10.1046/j.1445-5994.2001.00078.x |
|
2001 Journal Article Single institution outcomes of treatment of severe aplastic anaemiaMollee, P., Woodward, N., Durrant, S., Lockwood, L., Gillett, E. A., Morton, J. and Rowell, J. (2001). Single institution outcomes of treatment of severe aplastic anaemia. Internal Medicine Journal, 31 (6), 337-342. doi: 10.1046/j.1445-5994.2001.00078.x |
|
2001 Conference Publication Low dose valaciclovir for the prevention of CMV disease post allogeneic bone marrow transplantationIrving, I, Williamson, J, Mollee, P, Morton, AJ, Sloots, T, Siebert, D and Durrant, S (2001). Low dose valaciclovir for the prevention of CMV disease post allogeneic bone marrow transplantation. BASINGSTOKE: NATURE PUBLISHING GROUP. |
|
2001 Conference Publication Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.Durrant, S., Irving, I., Mollee, P., Morton, A. J., Webb, M. and Macfarlane, D. (2001). Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.. 27th Annual Meeting of the European Group for Blood and Marrow Transplantation, London, United Kingdom: Nature Publishing Group. |
|
2000 Conference Publication Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD.Mollee, P, Morton, J, Irving, I and Durrant, S (2000). Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD.. |
|
2000 Conference Publication A Phase II study of Interferon alpha and intermittent oral Cytarabine in the treatment of newly diagnosed Chronic Myeloid Leukaemia.Mollee, P., Taylor, K., Arthur, C., Wright, S., Rodwell, R. and Taylor, D. (2000). A Phase II study of Interferon alpha and intermittent oral Cytarabine in the treatment of newly diagnosed Chronic Myeloid Leukaemia.. Perth, July 2000. Sydney: Haematology Society of Australia and New Zealand. |
|
2000 Conference Publication A phase II study of interferon alpha (IFN) and intermittent oral cytarabine (YNK01) in the treatment of newly diagnosed chronic myeloid leukemia (CML)Mollee, P., Taylor, K., Arthur, C., Wright, S. and Morton, J. (2000). A phase II study of interferon alpha (IFN) and intermittent oral cytarabine (YNK01) in the treatment of newly diagnosed chronic myeloid leukemia (CML). 2nd Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, Perth, WA, 25-28 July 2000. Washington, D.C.: American Society of Hematology. |
|
1999 Journal Article Long-term molecular remission in promyelocytic transformation of myeloproliferative diseaseMollee, P. N., Taylor, K. M., Williams, B., Taylor, D. and Rodwell, R. (1999). Long-term molecular remission in promyelocytic transformation of myeloproliferative disease. Leukemia, 13 (4), 648-650. doi: 10.1038/sj.leu.2401358 |
|
1999 Journal Article Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factorMorton, J, Mollee, P, Taylor, K, Grigg, A, Durrant, S, Moore, D, Rodwell, R, Eliadis, P, Hutchins, C, Williams, B, Seeley, G, Wright, S, Kelly, C, Rentoul, A, Iland, H, Atkinson, K, Januszewicz, H, Bunce, I, Bashford, J, Stewart, C and Taylor, D (1999). Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor. Leukemia Research, 23 (2), 177-183. doi: 10.1016/S0145-2126(98)00143-X |
